Trial Profile
Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 25 Mar 2021
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Achalasia
- Focus Proof of concept; Therapeutic Use
- 22 Mar 2021 Status changed from recruiting to discontinued.
- 30 Jan 2018 New trial record